Biolife Solutions (BLFS) Income from Continuing Operations (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Income from Continuing Operations for 16 consecutive years, with 3513000.0 as the latest value for Q4 2025.
- On a quarterly basis, Income from Continuing Operations rose 689.44% to 3513000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 12130000.0, a 39.38% decrease, with the full-year FY2025 number at 12130000.0, down 38.08% from a year prior.
- Income from Continuing Operations was 3513000.0 for Q4 2025 at Biolife Solutions, up from 603000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 40885000.0 in Q4 2023 to a low of 91905098000.0 in Q4 2022.
- A 5-year average of 4600980300.0 and a median of 4358500.0 in 2023 define the central range for Income from Continuing Operations.
- Peak YoY movement for Income from Continuing Operations: plummeted 583609.74% in 2022, then soared 689.44% in 2025.
- Biolife Solutions' Income from Continuing Operations stood at 15745000.0 in 2021, then tumbled by 583609.74% to 91905098000.0 in 2022, then soared by 100.04% to 40885000.0 in 2023, then crashed by 98.91% to 445000.0 in 2024, then skyrocketed by 689.44% to 3513000.0 in 2025.
- Per Business Quant, the three most recent readings for BLFS's Income from Continuing Operations are 3513000.0 (Q4 2025), 603000.0 (Q3 2025), and 15798000.0 (Q2 2025).